These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26854824)

  • 1. Differential cytotoxic effects of 7-dehydrocholesterol-derived oxysterols on cultured retina-derived cells: Dependence on sterol structure, cell type, and density.
    Pfeffer BA; Xu L; Porter NA; Rao SR; Fliesler SJ
    Exp Eye Res; 2016 Apr; 145():297-316. PubMed ID: 26854824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
    Xu L; Sheflin LG; Porter NA; Fliesler SJ
    Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith-Lemli-Opitz Syndrome.
    Pfeffer BA; Xu L; Fliesler SJ
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
    Fliesler SJ; Xu L
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome.
    Fliesler SJ; Peachey NS; Herron J; Hines KM; Weinstock NI; Ramachandra Rao S; Xu L
    Sci Rep; 2018 Jan; 8(1):1286. PubMed ID: 29352199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
    Vaughan DK; Peachey NS; Richards MJ; Buchan B; Fliesler SJ
    Exp Eye Res; 2006 Mar; 82(3):496-504. PubMed ID: 16360150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
    Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
    J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
    Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
    Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome.
    Korade Z; Xu L; Harrison FE; Ahsen R; Hart SE; Folkes OM; Mirnics K; Porter NA
    Biol Psychiatry; 2014 Feb; 75(3):215-22. PubMed ID: 23896203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.
    Xu L; Korade Z; Rosado JDA; Liu W; Lamberson CR; Porter NA
    J Lipid Res; 2011 Jun; 52(6):1222-1233. PubMed ID: 21402677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
    Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
    Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
    Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
    J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
    Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
    Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.
    Tomita H; Hines KM; Herron JM; Li A; Baggett DW; Xu L
    Elife; 2022 Sep; 11():. PubMed ID: 36111785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome.
    Korade Z; Xu L; Shelton R; Porter NA
    J Lipid Res; 2010 Nov; 51(11):3259-69. PubMed ID: 20702862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.
    Xu L; Mirnics K; Bowman AB; Liu W; Da J; Porter NA; Korade Z
    Neurobiol Dis; 2012 Mar; 45(3):923-9. PubMed ID: 22182693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts.
    Kelley RI
    Clin Chim Acta; 1995 Apr; 236(1):45-58. PubMed ID: 7664465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
    Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
    J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
    Keller RK; Arnold TP; Fliesler SJ
    J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols.
    Sever N; Mann RK; Xu L; Snell WJ; Hernandez-Lara CI; Porter NA; Beachy PA
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5904-9. PubMed ID: 27162362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.